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ABSTRACT
The transition of embryonic stem cell (ESC) pluripotency to differentiation is accompanied by an
expansion of mRNA and proteomic diversity. Post-transcriptional regulation of ESCs is critically
governed by cell type-specific splicing. However, little is known about the splicing factors and
the molecular mechanisms directing ESC early lineage differentiation. Our study identifies RNA
binding motif protein 24 (Rbm24) as a key splicing regulator that plays an essential role in con-
trolling post-transcriptional networks during ESC transition into cardiac differentiation. Using an
inducible mouse ESC line in which gene expression could be temporally regulated, we demon-
strated that forced expression of Rbm24 in ESCs dramatically induced a switch to cardiac speci-
fication. Genome-wide RNA sequencing analysis identified more than 200 Rbm24-regulated
alternative splicing events (AS) which occurred in genes essential for the ESC pluripotency or
differentiation. Remarkably, AS genes regulated by Rbm24 composed of transcriptional factors,
cytoskeleton proteins, and ATPase gene family members which are critical components required
for cardiac development and functionality. Furthermore, we show that Rbm24 regulates ESC dif-
ferentiation by promoting alternative splicing of pluripotency genes. Among the Rbm24-
regulated events, Tpm1, an actin filament family gene, was identified to possess ESC/tissue spe-
cific isoforms. We demonstrated that these isoforms were functionally distinct and that their
exon AS switch was essential for ESC differentiation. Our results suggest that ESC’s switching
into the differentiation state can be initiated by a tissue-specific splicing regulator, Rbm24. This
finding offers a global view on how an RNA binding protein influences ESC lineage differentia-
tion by a splicing-mediated regulatory mechanism. STEM CELLS 2016; 00:000—000
SIGNIFICANCE STATEMENT
This study reports a novel function and post-transcriptional regulatory mechnism of an RNA
binding protein Rbm24 in embryonic stem cells (ESC) differentiation. Our results suggest that
ESC switching into the differentiation state can be initiated by a tissue-specific splicing regula-
tor. To our knowledge, this is the first report describing an RNA binding protein controlling
ESC commitment to cardiac lineage specification by engaging a splicing mechanism. Our find-
ings would significantly add to the understanding of the mechanisms in ESC differentiation and
heart development, and uncover potential novel pathways operating to direct differentiation
of ESCs into cardiomyocytes for envisioned regenerative therapies.
INTRODUCTION
Embryonic stem cells (ESCs), with their ability
to differentiate into multicell lineages, hold
remarkable potential for cell replacement
therapies. The potential of these cells in thera-
peutic application can be further enhanced
through better understanding of the crucial
molecular switches that regulate early ESC dif-
ferentiation. ESC differentiation involves
changes in transcription, and transcription fac-
tor networks have been shown to play a major
role in reorganizing the transcriptome of ESCs
in response to differentiation signals [1]. But
little is known about the post-transcriptional
changes during early lineage differentiation.
Alternative splicing (AS) of RNA, a major
form of post-transcriptional gene regulation, is
important in mammalian development [2, 3].
AS is a process by which splice sites in primary
transcripts are differentially selected to pro-
duce structurally and functionally distinct
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mRNA and protein isoforms, thus providing an additional
mechanism which controls cell fate [2, 4–8]. However, the
role of AS in self-renewal, pluripotency, and tissue lineage
specification of ESC remains largely unknown.
Recent studies based on genome-wide changes associated
with AS during differentiation of ESCs have highlighted the
importance of post-transcriptional RNA processing in cell fate
decision and differentiation [5, 9, 10]. In a comparison of
human ESCs before and after differentiation into cardiac or
neural progenitors, Salomonis et al. [5] identified hundreds of
AS events between ESCs and differentiated cells, with
observed conservation of AS events between mouse and
human. Dramatic splicing changes are frequently found during
ESC differentiation, and RNA-binding proteins (RBPs) are
known to be essential for AS regulation in shaping gene
expression during the dynamic process of development [11].
However, it remains unclear to what extent these AS events
direct lineage-specific differentiation, and which RBPs are
responsible for their regulation.
We have previously reported that RNA binding motif pro-
tein 24 (Rbm24) is enriched in human ESCs-derived cardiomy-
ocytes and is highly expressed in human and mouse heart
[12, 13]. We further characterized the functional role of
Rbm24 in the regulation of cardiac gene expression, sarco-
meric assembly, and cardiac contractility in a zebrafish loss-of-
function model. Rbm24 deficiency results in diminished heart
contractility and the absence of circulation in zebrafish
embryos [14]. Grifone et al. [15] also reported the expression
of Rbm24 in mouse heart and showed that Rbm24 was
required in myogenesis of skeletal muscle in chick. These find-
ings revealed the novel role of the tissue-specific Rbm24 in
heart and skeletal development.
Recently, Yang et al. [16] reported that targeted inactiva-
tion of Rbm24 disrupted development in mouse. This was
consistent with our previous observations in zebrafish [14]
where Rbm24 deficiency led to severe sarcomeric disarrange-
ment in striated muscles of the mouse heart [16]. Further-
more, the authors found that Rbm24 null mice died between
embryonic day E12.5 and E14.5, showing multiple cardiac mal-
functions. RNA-seq analysis of the knockout (KO) hearts iden-
tified 68 Rbm24-dependent splicing events, in which several
of them were implicated to be responsible for a defective
heart phenotype [16]. However, it remains unclear if the
observed Rbm24 KO phenotype is the consequence of early
cardiogenesis defects which accumulated until late develop-
ment, leading to embryo lethality.
Our previous study showed that the expression of Rbm24
was upregulated in day 3 of human ESCs differentiation into
cardiomyocytes, and the mouse Rbm24 transcript was
detected in the cardiac mesoderm at E7.0, the earliest stage
analyzed in the study [17]. Notably, in zebrafish, Rbm24
expression was detected as early as 16-cell stage before gas-
trulation [18]. Based on these observations, we hypothesized
that Rbm24 might play a crucial role in the early differentia-
tion of ESCs to cardiomyocytes.
To dissect the cellular and the molecular mechanism by
which Rbm24 acts during cardiac specification, an inducible
Rbm24 expression system using mouse ESCs was constructed
[19]. High throughput RNA-seq analysis was used to analyze
the genome-wide transcriptome and the AS events regulated
by Rbm24. Our results indicate that Rbm24 is crucial for ESC
early differentiation and required for more than 200 splicing
events. We further show that overexpression of Rbm24 pro-
motes, whereas knockdown (KD) of Rbm24 inhibits ESC car-
diogenesis. Importantly, we demonstrate that Rbm24 directs
ESC early differentiation toward the cardiac lineage via activa-
tion of specific splicing of cardiac-related RNAs coding for
transcription factors, cytoskeletal proteins, and ATPase compo-
nents. Furthermore, we show that Rbm24 controls proper
splicing of ESC/tissue specific isoforms encoding for Tpm1.
These isoforms function distinctly in ESC switching from pluri-
potency to differentiation. KD of ESC-specific the Tpm1 iso-
form markedly affected the maintenance of ESC pluripotency.
MATERIALS AND METHODS
Generation of Doxycycline Inducible Rbm24 ESC Line
Human Rbm24 was sequenced and subcloned into p2Lox-
Mesp1-Flag-IRES-GFP plasmid [19] in place of Mesp1 to obtain
p2Lox-Rbm24-Flag-IRES-GFP plasmid. This construct was elec-
troporated in A2Lox cells as described previously [19, 20]. Two
days after electroporation, the recombined cells were selected
by using 300lg/ml of G418 for 1 week.
ESC Culture and Differentiation
A2Lox ESC and R1 ESC lines were routinely maintained on
mouse embryonic fibroblasts (MEFs) as described [20, 21].
Medium composition and differentiation protocol are
described in Supporting Information Experimental Procedures.
Rbm24 KD ESC Construction
R1 ESCs (ATCC, Manassas, VA, http://www.atcc.org) were
infected with lentivirus expressing short hairpin RNA (shRNA)
targeting mouse Rbm24 gene (Santa Cruz Biotechnology, Dal-
las, TX, http://www.scbt.com) and selected with puromycin
for 4 days, nontargeting viral particles were used as a control
(Ctl). R1 cells were differentiated into embryoid bodies (EBs)s
and screened at days 0, 3, 6, 9, and 12, for KD efficiency by
both quantitative real-time polymerase chain reaction (qRT-
PCR) and Western blot.
RNA-seq
A2Lox ESCs were cultured feeder-free prior to doxycycline
(Dox) induction. Total RNAs isolated from biological duplicates
of Rbm24 induced (1Dox) for 48 hours and noninduced
(2Dox) were used to prepare RNA-seq library according to
manufacturer’s instruction (Illumina, http://www.illumina.
com). The cDNA library was sequenced on the Illumina
sequencing platform (Illumina HiSeq 2500, San Francisco)
using paired-end technology. Sequencing reads in FASTQ for-
mat were mapped to the reference genome, and splice junc-
tions were identified using TopHat [22]. Cufflinks and Cuffdiff
were used for transcript reconstruction, quantification, and
differential expression analysis [23]. Abundances were
reported in FPKM (fragments per kilobase of transcript per
million fragments mapped). Further details are documented in
Supporting Information Experimental Procedures.
Experimental Assay of AS
Specific primers flanking predicted sites of AS were used
for RT-PCR amplifications. PCR products were separated by
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high-resolution agarose gel electrophoresis. All primers used
in assay are listed in Supporting Information Experimental
Procedures.
RT-PCR, qRT-PCR, Immunostaining, Western-Blot, FACS,
and Electrophysiology
Detailed protocols are provided in the Supporting Information
Experimental Procedures.
Statistical Analysis
All of the results are presented as mean6 SD. All data were
statistically analyzed by Student’s t test, p value< .05 was
considered to be statistically significant.
RESULTS
Overexpression of Rbm24 Promotes Differentiation
of ESCs
We first examined Rbm24 expression during mouse ESC differ-
entiation by performing qRT-PCR after 0, 1, 2, 3, 6, and 12
days of differentiation (Fig. 1A). Pluripotency markers Oct4
and Nanog were rapidly downregulated while the mesoderm
marker T-brachyury (T-Bra) and cardiac mesoderm marker
Mesp1 were upregulated. The expression of Rbm24 was also
upregulated from day 3 when cardiomyocyte differentiation
markers start to be detected. Its expression increased by day
6 and continued to elevate along with early cardiomyocyte-
specific transcription factor Nkx2.5.
In an attempt to identify Rbm24-regulated molecules that
could potentially be involved in early ESC differentiation, we
generated a recombinant A2Lox ES cell line in which the
expression of the recombinant flag-tagged version of Rbm24
with an IRES-GFP (green fluorescent protein) can be tempo-
rally and specifically induced with Dox (Fig. 1B; Supporting
Information Fig. S1) [19–21]. In the absence of Dox, no
expression of the transgene was detected by fluorescence
microscopy (Fig. 1C). Upon Dox induction, GFP expression was
clearly detected (Fig. 1C; Supporting Information Fig. S1B).
Western blot showed that Rbm24 protein was pronouncedly
expressed at 12 hours post-Dox administration in ESCs and
increased after 24 hours postinduction (Fig. 1D). Flow cytome-
try analysis demonstrated that up to 98.23% of ESCs
expressed the GFP reporter gene (Fig. 1E).
To determine if Rbm24 directly promotes ESC differentia-
tion, Rbm24 was overexpressed in ESCs cultured in the
feeder-free ESC medium without leukemia inhibitory factor
(LIF). We then monitored the morphology of ESC clones.
Seventy-two hours after LIF withdrawal, ESCs treated with
Dox displayed a differentiated morphology, whereas untreated
ESCs did not (Fig. 1F). Notably, Rbm24 overexpression
resulted in the reduction of alkaline phosphatase (Fig. 1G)
and Oct4 staining (Fig. 1H), suggesting Rbm24 overexpression
affected ESC pluripotency.
Rbm24 Promotes Cardiac Lineage Specification
from ESCs
We used the Rbm24 inducible system to identify the role and
mechanism of action of Rbm24 in ESC lineage differentiation.
A schematic diagram of the experimental strategy is illus-
trated in Figure 2A. We first examined whether overexpres-
sion of Rbm24 could promote ESC differentiation toward
specific lineages when ESCs were cultured under mild differ-
entiated condition in the feeder-free ESC medium without LIF.
qRT-PCR was used to analyze the expression of markers spe-
cific for ESC lineage differentiation. As shown in Figure 2B,
upon Dox induction, mesoderm marker T-Bra, cardiac meso-
derm marker Mesp1, and cardiac progenitor markers Nkx2.5
and Mef2c were significantly upregulated. This suggests that
Rbm24 promoted ESC differentiation to mesoderm and car-
diac lineage. It is noted that expression of pluripotency
markers Oct4 and Nanog remained almost unchanged, while
Lefty1 was downregulated, suggesting ESCs were undergoing
partial differentiation triggered by Rbm24 overexpression. The
expression of early endoderm marker Sox17 was moderately
upregulated, but late marker AFP was dramatically downregu-
lated, suggesting Rbm24 could contribute to mesoendodermal
differentiation of ESCs, but could have a negative impact on
the late endoderm lineage. The expression of ectoderm
marker Nestin and Sox1 remained unchanged, suggesting
Rbm24 did not influence ectoderm differentiation. Together,
these results demonstrate that Rbm24 overexpression pro-
motes ESC transition to cardiac differentiation.
We next investigated whether Rbm24 stimulates ESCs to
generate cardiac cells more efficiently. We performed cardiac
differentiation using the EB method as described [19]. As
shown in Figure 2C, the induction of Rbm24 resulted in an
accelerated cardiac differentiation, which occurred at day 8 of
cardiac differentiation, a day earlier than in untreated cells.
Close observation of the EB cultures revealed an increased
number of beating zones within EB cultures that have been
stimulated with Rbm24 overexpression (Fig. 2C; Supporting
Information Videos). Immunofluorescence staining demon-
strated the increased expression of cardiac specific markers
Nkx2.5, Tpm, Actn2, Tnnt2, Myh6, Mlc2a, and Mlc2v, following
Rbm24 induction (Fig. 2D). Confocal microscopy imaging
revealed characteristic cross-striation typical of sarcomeric
structures in some Rbm24-induced cells, as exemplified in
Supporting Information Figure S2A.
To further provide a quantitative assessment of the car-
diac differentiation efficiency, we performed fluorescence acti-
vated cell sorting (FACS) analysis on the expression of Actn2
after 12 days of differentiation. As shown in Figure 2E,
Rbm24-stimulated cells generated about six times more car-
diac cells. Time-course qRT-PCR assay further highlighted
that Rbm24 induction increased the expression of cardiac
specific markers during differentiation (Supporting Information
Fig. S2B). These results demonstrated that forced expression
of Rbm24 in ESCs enhanced the efficiency of cardiac
differentiation.
To characterize the electrophysiological properties of cardi-
omyocytes generated from ESCs, we performed patch clamp
assay on beating cells to assess action potentials (APs) at day
12 and 19 after differentiation. Three major types of APs
(nodal-like, atrial-like, and ventricular-like) were detected in
both Rbm24 induced beating cells (day 12, n 5 14; day 19,
n 5 16) and uninduced controls (day 12, n 5 8, day 19, n 5 9).
The majority of cells under both conditions were atrial-like or
ventricular-like. Both groups displayed similar AP pattern for
day 12 and 19 beating cells, and proportions of atrial and
ventricular-like cells had no statistically significant differences
Zhang, Lin, Liu et al. 3
www.StemCells.com VC AlphaMed Press 2016
Figure 1. Rbm24 regulates differentiation of ESCs. (A): Expression profiles of pluripotency markers (Oct4 and Nanog), mesodermal
markers (Mesp1 and T-Bra), Rbm24, and cardiac marker (Nkx2.5) during normal ESC differentiation by embryoid body (EB) formation as
measured by quantitative real-time polymerase chain reaction. Data were normalized to Gapdh. Error bars represent mean6 SD from
three biologically independent experiments. (B): Schematic diagram depicting the methodology for generating an ESC line for inducible
expression of Rbm24 by DOX. Upper panel: Inducible cassette exchange recombination in A2Lox ESCs (Supporting Information Fig. S1A);
lower panel: experimental procedure. (C): Rbm24-IRES-GFP expression following induction of A2lox ESCs with doxycycline (1Dox) for 48
hours. No GFP expression was detected in uninduced cells (2Dox). Scale bar5 200lm (Supporting Information Fig. S1B for 24-hour Dox
induction). (D): Kinetics of Rbm24 expression using Western blot with anti-Rbm24 antibody. Rbm24 was almost undetectable in uninduced
condition but was rapidly upregulated following Dox stimulation. (E): GFP expression as measured by flow cytometry after Dox induction
for 48 hours in ESCs. (F): Overexpression of Rbm24 for 3 days by Dox induction leads to an altered morphology of ESCs. (G): Alkaline phos-
phatase staining and (H) immunofluorescence staining of Oct4 at day 3 following induction of Rbm24 by Dox in the absence of feeder cells
and LIF. Scale bar5 200lm. Abbreviations: Dox, doxycycline; ESC, embryonic stem cell; GFP, green fluorescent protein; T-Bra, T-brachyury.
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Figure 2. Rbm24 overexpression promotes cardiac differentiation of ESCs. (A): Schematic overview of experimental strategy. Assays
were performed at different time points as described in the Results section are as indicated in the diagram. (B): Quantification of pluri-
potency markers (Oct4, Nanog, and Lefty1), lineage markers (Nestin, Sox1, Sox17, AFP, T-bra, and Mesp1), and cardiac markers (Nkx2.5,
Mef2c and Gata4) analyzed by qRT-PCR after 48 hours of Rbm24 induction in ESC medium in the absence of leukemia inhibitory factor.
Note that Rbm24 induces the expression of cardiac mesoderm markers Mesp1 and T-bra significantly. Data represent relative expression
of transcripts compared to untreated ESCs as mean6 SD of three biologically independent experiments. (*, p< .05; **, p< .01; ***,
p< .001). (C): Rbm24 overexpression promotes cardiac commitment in EB cultures as detected by the precocious appearance and
enhancement of beating areas, compared to uninduced cells (Supporting Information video). Error bars represent mean6 SD from five
biologically independent experiments. (D): Immunofluorescence staining of beating cells. Day 11 EBs were dissociated and plated on
chamber slides and stained with Nkx2.5, Tpm, Actn2, Tnnt2, Myh6, Mlc2a, and Mlc2v antibodies, the specific markers for cardiomyocyte.
Scale bar5 200 lm. (E): Quantification of cardiomyocytes by flow cytometry. At day 12 after cardiac differentiation of ESCs, EBs were
dissociated and stained for cardiac-specific marker Actn2. (F): Patch-clamp electrophysiology showed representative ventricular-like,
atrial-like, and nodal-like action potentials of ESC-derived cardiomyocytes. Beating EBs were enzymatically dissociated to single cells and
action potentials (APs) were assessed. Types of APs were recorded in cardiomyocytes isolated from 19 days EBs after differentiation
with Rbm24 induction. The same types of APs were recorded in control cells. Abbreviations: Dox, doxycycline; EB, embryoid body; ESCs,
embryonic stem cells; FACS, fluorescence activated cell sorting; qPCR, quantitative polymerase chain reaction.
between two groups. Representative APs from the Rbm24
induced group on day 19 are shown in Figure 2F.
Genome-Wide Profiling Identifies
Rbm24-Regulated Genes
To uncover the molecular mechanisms by which Rbm24
induced ESC differentiation, we performed a genome-wide
analysis of Rbm24-regulated genes using high throughput RNA
sequencing (RNA-seq) technology. This allows us to determine
transcriptomic changes and assess the extent to which ESC-
differential AS events are controlled by Rbm24.
Firstly, we examined the differential gene expression to
identify genome-wide molecular phenotype alteration in
response to Rbm24 overexpression. Approximately 586 genes
exhibited a 1.5-fold or greater change in response to Rbm24
overexpression (Fig. 3A; Supporting Information Dataset1).
Notably, overexpression of Rbm24 increased mRNA of sarco-
meric protein Actn2, which is a cardiac marker, by about
eightfold. This result was verified by qRT-PCR (data not
shown), suggesting that Rbm24 may directly regulate mRNA
level of Actn2.
To obtain a functional overview of the genes responsive
to overexpression of Rbm24, we grouped expression data
into Gene Ontology (GO) categories using DAVID (http://
david.abcc.ncifcrf.gov/). Genes that show increased expres-
sion are enriched in development, differentiation, actin-
binding, and cytoskeletal protein binding (Fig. 3B), and genes
that show decreased expression are enriched in antioxidant
activity which is known to inhibit cardiac differentiation (Fig.
3C) [24]. This further highlights that ESCs have transitioned
to undergo differentiation to cardiomyocytes upon Rbm24
induction.
Figure 3. RNA-seq analysis of gene expression regulated by Rbm24. (A): A scatter plot depicting the differentially expressed genes fol-
lowing Dox induction. Red dots represent upregulated genes, and green dots represent downregulated genes. (B): Gene ontology analy-
sis of upregulated genes after 48 hours Rbm24 induction. (C): Gene ontology analysis of downregulated genes after 48 hours Rbm24
induction. Abbreviation: Dox, doxycycline.
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Identification of Rbm24-Regulated AS Events and
Associated Pathways in ESC Differentiation
To identify the AS events following Rbm24 overexpression,
an algorithm based on Cufflinks was used to assign reads to
known transcripts and calculate their abundance (Fig. 4A)
[23]. We selected the transcripts greater than fourfold
change upon Rbm24 induction and FPKM 4 at least in one
sample. Approximately 247 differentially spliced transcripts
belong to 230 genes were identified to be AS regulated by
overexpression of Rbm24 (Supporting Information Dataset2).
To assess the reliability of the data, we checked the
isoform-switch of Naca, a previously known target of Rbm24
[16], in our RNA-seq data. As shown in Supporting Informa-
tion Figure S3, Rbm24 overexpression significantly increased
the expression of cardiac-isoform skNac, but not the aNac,
in accordance with the early report [16]. We further vali-
dated four AS events using RT-PCR. As shown in Figure 4B,
Dox induction changed the isoform patterns of each
detected gene, giving us high confidence in our RNA-seq
analysis.
To further validate our in vitro ESC differentiation observa-
tion, we compared 230 genes with Rbm24-regulated AS
events which were from the RNA-seq data of the Rbm24
knockout mouse [16]. Approximately 11 genes overlapped
with the previously reported Rbm24-dependent 68 AS events
in the heart (calculated as 16% overlapping) including Naca,
Myo18a, Cad, Add1, Rnps1, Cald1, Actb, Cox7a2l, Atp5c1,
Slc25a3, and Tpm1 [16]. This suggests the fidelity of our RNA-
seq data and reinforces the splicing role of Rbm24 in regulat-
ing heart development. Notably, these 11 overlapping AS
genes were detected in two different biological systems,
which are Rbm24 knockout mouse heart [16] and Rbm24
overexpressing ESCs (this study) by independent RNA-seq
assays, indicating these genes might be the direct splicing tar-
gets of Rbm24.
To assess the potential functionality of Rbm24-regulated
AS genes, we grouped them into GO categories. The 230
genes were classified according to GO annotations. Figure 4C
presents subcategories (p< .05) of molecular components, in
which “cytoskeleton” and “kinase activity” were reported sig-
nificantly enriched in terms of AS during ESC differentiation
[8]. Other subcategories, such as RNA binding and transla-
tion factor activity, are predominantly related to post-
transcriptional regulations. As shown in Figure 4D, the analy-
sis also pointed to processes involved in cardiac differentia-
tion of ESCs such as cytoskeleton organization, cell division,
cell cycle, and response to stress. Finally, significant (p< .05)
subcategories of cellular components are shown in Figure
4E. Our analysis pointed to components involved in cardiac
cell structure and function such as cytoskeleton and
mitochondrion.
We also searched our RNA-seq data against the Kyoto
Encyclopedia of Genes and Genomes database (KEGG, http://
www.kegg.com [25]). As shown in Supporting Information
Table S1, nine pathways were identified when applying
software-defined significance criteria (p< .05) including splice-
some, regulation of actin cytoskeleton, cardiomyopathies,
adherens junction, and mRNA surveillance, indicating an
essential role of Rbm24 in RNA regulation and heart function.
Taken together, these results demonstrate that Rbm24 is a
major splicing factor regulating AS events important in ESC
cardiac differentiation.
Rbm24-Regulated AS Contributes to ESC Cardiogenesis
Notably, as demonstrated by GO and KEGG analysis, the
global RNA-seq analysis identified classes of genes with cell-
type-specific functions, that appear to be constitutively
expressed in ESCs. As exemplified in Supporting Information
Figure S4, some of them have high mRNA expression levels
comparable to pluripotency genes Oct4 and Nanog. These
genes are well-documented to play a role in the heart and/or
muscle, for example, tropomyosin protein Tpm1, 2, 3 [26],
Tnnt1 [27], and Ak1 [28]. By contrast, little data is available
regarding the expression and role of these genes in undiffer-
entiated or differentiated states of ESCs.
From our GO analysis, we found that Rbm24 regulated
transcripts were enriched in cytoskeleton and mitochondrion
function (Figs. 4E, 5A). Heart and skeletal muscle cells have
specific cytoskeleton and actin-binding systems to support
their contractile function and specific mitochondrion to supply
high levels of energy. Given that Rbm24 is specifically
expressed in muscle cells, we speculated that our identified
Rbm24-associated constitutive genes could be spliced by
Rbm24 during differentiation to produce specific isoforms to
implement tissue-specific function.
To test our hypothesis, we selected eight genes to investi-
gate whether their splicing patterns are correlated with
Rbm24 regulation during ESC differentiation toward cardiomy-
ocytes. Among the eight genes, Naca could be spliced to pro-
duce skNac which is a muscle-specific transcription factor
[29], while Tpm1, Capzb, and Tpm3 are related to the cyto-
skeleton. Itga6 is an actin binding protein and modulates the
expression of a large number of cell migration-related genes
[30]. Atp5c1 (ATP synthase gamma-subunit) has an AS isoform
specifically expressed in both heart and skeletal muscle [31].
Enah is localized to the Z-disc and is required for beta-actin
assembly at Z-disc of cardiac muscles [32]. Sun1 plays an
essential role in proper myonuclear positioning in mouse skel-
etal muscle [33].
Firstly, we investigated whether these Rbm24-regulated
AS events could occur during the onset of ESC differentiation.
As shown in Figure 5B, all AS events were detected in ESCs
upon Dox induction, indicating that these transcripts are pre-
existing and spliced by Rbm24 in the course of ESC transition
into differentiation. Subsequently, we investigated whether
Rbm24-regulated AS events occur during ESC differentiation
into cardiomyocytes. As shown in Figure 5C, all genes dis-
played an Rbm24-regulated AS pattern at day 6 and increased
at day 12, along with upregulation of Rbm24 and early
cardiomyocyte-specific transcription factor Nkx2.5 (Fig. 1A).
This indicates that Rbm24-regulated AS patterns are related
to cardiac differentiation of ESCs. It is interesting to note that
the splice isoforms of these genes are also present in normal
mouse cardiac/muscle tissues (see Supporting Information
Result and Fig. S5). Enah gene displayed similar AS patterns
as verified by qRT-PCR (Supporting Information Fig. S6). In all,
our results suggest that Rbm24 promotes ESC differentiation
toward cardiomyocytes by splicing constitutive genes (such as
Capzb, Naca, Sun1, and Atp5c1) or muscle-specific genes
(such as Tpm1, Tpm3, and Enah) to produce cardiac isoforms.
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Figure 4. RNA-seq analysis of alternative splicing (AS) events regulated by Rbm24. (A): Overview of algorithm to analyze Rbm24-
regulated AS events. Sequences of cDNA fragments generated from high throughput sequencing were aligned to the genome by a
spliced aligner (Tophat) [22]. Cufflinks was then used to assemble transcript structures and estimate transcript abundance [23]. (B):
Validation of RNA-seq data by real-time polymerase chain reaction (RT-PCR). Naca has two isoforms, skNac and aNac, generated by
alternative splicing a 6 kb exon 2. Two primer pairs were used to amplify these two isoforms, respectively. Hprt was used as an
internal control. 30 cycles of PCR were performed. (C): Gene ontology analysis of Rbm24-regulated AS events (molecular function).
(D): Gene ontology analysis of Rbm24-regulated AS events (biological process). (E): Gene ontology analysis of Rbm24-regulated AS
events (cellular component). Abbreviation: Dox, doxycycline; FPKM, fragments per kilobase of transcript per million fragments
mapped.
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KD of Rbm24 Inhibits Cardiac Differentiation of ESCs
Next, we investigated whether Rbm24 is required for ESC car-
diac differentiation, and whether the observed cardiac-specific
AS events are Rbm24 dependant. We generated an Rbm24 KD
stable cell line using Rbm24 shRNA-expressing lentivirus in R1
ESCs. As shown in Figure 6A, 6B, shRNA efficiently depleted
Rbm24 expression at the mRNA and protein levels during car-
diac differentiation. Notably, cardiogenesis in Rbm24-KD ESCs
were significantly inhibited, no beating area was detected until
day 16, and only a small portion of beating area was observed
when differentiation was prolonged to day 17 (Fig. 6C). We fur-
ther analyzed the expression of markers specific for cardiac dif-
ferentiation by qRT-PCR. As shown in Figure 6D, expression of
cardiac markers Nkx2.5, Gata4, and Myh6 was significantly
reduced in Rbm24 KD cells. KD of Rbm24 also decreased the
expression of early mesoderm marker Mesp1 and endoderm
marker Sox17 but increased the expression of ectoderm
markers Nestin and Sox1. This suggests that Rbm24 deficiency
impaired endoderm and mesoderm differentiation, inversely
correlating with our observations in the Rbm24 overexpression
experiments (Fig. 2B; Supporting Information Fig. S2B).
As we have shown the above Rbm24-regulated AS pat-
terns occur during ESC differentiation into cardiomyocytes
(Fig. 5C), we then investigated whether Rbm24-regulated AS
events were perturbed in Rbm24 KD ESC differentiation. As
shown in Figure 6E, Rbm24-regulated AS patterns are dramati-
cally alerted at day 6 and day 12 in the Rbm24 KD cells, sug-
gesting that the expression of alternative isoforms of these
genes are Rbm24 dependent and correlated with ESC cardiac
differentiation. We further confirmed this observation for four
additional genes by qRT-PCR (Supporting Information Fig. S7).
Additional AS assays were also performed using alternative
cell line of mouse cardiac HL-1 to substantiate this finding
(Supporting Information Results; Fig. S8). Together, these
results demonstrate that Rbm24 is required for ESC cardiac
differentiation by regulating cardiac specific AS events.
Figure 5. Rbm24-regulated alternative splicing (AS) events are related to cardiac differentiation. (A): Rbm24-regulated AS events are
enriched in the mitochondrion and cytoskeleton. (B): Real-time polymerase chain reaction (RT-PCR) analysis of Rbm24-regulated AS
events in ESCs with or without Rbm24 induction. RNA was isolated 48 hours after Dox induction. Hprt was used as an internal control.
Schematics of all splicing events are shown. i1-exclusion isoform (exon excluded); i2-inclusion isoform (exon included). Upregulation of
i2 isoform of Tpm1, Capzb, Tpm3, Itga6, Sun1, and skNac was detected upon Dox treatment. Atp5c1 displayed exon exclusion AS pat-
tern, i1 was upregulated by Rbm24. (C): Time-course analysis of AS events by RT-PCR during A2Lox ESC differentiation toward cardiomy-
ocytes. Differential expression of AS events (observed in Fig. 5B) was detected in EBs 6 and 12 days after cardiac differentiation. i1/i2
are annotated as per Figure 5B. Hprt was used as an internal control. Abbreviations: DOX, doxycycline; ESC, embryonic stem cell.
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Rbm24 Regulates Differentiation by Promoting
AS of Pluripotency Genes
As noted above, overexpression of Rbm24 decreased the plu-
ripotency of ESCs (Fig. 1F–1H), we next examined whether
splicing of pluripotency-associated genes would possibly be
regulated by Rbm24. We compared Rbm24-regulated AS tran-
scripts with genes essential for ESC maintenance as previously
identified by large-scale RNAi screening in human ESCs [34].
Thirteen genes were found to overlap in this comparison (Fig.
7A). We therefore asked whether Rbm24 is potentially
involved in the regulation of these splicing events.
Tpm1 was reported to have an ESC-specific isoform (Fig. 7B)
[8], so it was selected from the list of 13 pluripotency genes to
investigate whether Rbm24 decreased the proportion of ESC iso-
form. We quantified the ratio of the expression level between
isoforms with exon5 (ESC- isoform, Tpm1-E5) and exon6 (tissue-
isoform, Tpm1-E6) in ESC cardiac differentiation by qRT-PCR. As
shown in Figure 7C, Tpm1-E5 is about twice the expression level
in ESCs compared to Tpm1-E6. The ratio of mRNA with Tpm1-E5/
Tpm1-E6 progressively decreased during cardiac differentiation,
indicating dynamic alternation of expression levels between the
two isoforms during ESC transition from pluripotency to a differ-
entiated state. We then checked if the AS regulation of Tpm1-E5
Figure 6. Rbm24 is required for embryonic stem cell (ESC) cardiogenesis. (A): Quantitative real-time polymerase chain reaction (qRT-
PCR) of day 6 and 12 EBs after ESC (R1 line) cardiac differentiation showed efficiency of Rbm24 shRNA-lentivirus knockdown (KD) at
transcript level. Data were normalized to Gapdh. Error bars represent mean6 SD from three biologically independent experiments (***,
p< .001). (B): Western blot of day 0, 3, 6, 9, and 12 EBs after cardiac differentiation showed depletion of Rbm24 protein in shRNA KD
cells. Gapdh was used as an internal control. (C): Rbm24 KD inhibited ESC cardiac differentiation as demonstrated by barely detectable
beating EBs in shRNA KD cells compared to control. Error bars represent mean6 SD from three biologically independent experiments.
(D): Temporal analysis of marker expression in ESC differentiating over 12 days in Rbm24 KD versus control cells by qRT-PCR. Data were
normalized to Gapdh. Error bars represent mean6 SD from three biologically independent experiments. (E): AS patterns of day 0, 3, 6,
and 12 EBs after cardiac differentiation were compared between Rbm24 KD cells and control cells by RT-PCR. i1/i2 are annotated as per
Figure 5B. Gapdh was used as an internal control. Abbreviation: EB, embryoid body.
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and Tpm1-E6 was controlled by Rbm24. As shown in Figure 7D,
Rbm24 overexpression decreased the expression of ESC-specific
Tpm1-E5 and increased the expression of tissue-specific Tpm1-E6.
To further investigate whether Tpm1 isoforms are func-
tional in ESC pluripotency, we designed isoform-specific siR-
NAs to KD Tpm1-E5 or E6, respectively in ESCs (Fig. 7E). As
Figure 7. Rbm24 regulates alternative splicing of pluripotency genes. (A): Venn diagram showing the overlap of hESC identity mainte-
nance genes with genes splicing regulated by Rbm24. Genes essential for hESC maintenance were extracted from Supporting Informa-
tion Table S1 of genome-wide RNAi screen in hESCs [34]. (B): Diagram of Tpm1 splicing patterns in ESCs versus tissues, primers
designed for qRT-PCR detection are indicated by black arrows. (C): Quantitative real-time polymerase chain reaction (qRT-PCR) analysis
indicates a Tpm1 splicing isoform switch during cardiac differentiation of ESCs. Data were normalized to Gapdh. Note the alternation of
expression levels between two isoforms during ESC differentiation as indicated by the decreased ratio of mRNA with exon5 versus
exon6. (D): Rbm24 decreased the expression of ESC-specific exon 5 and increased the expression of tissue-specific exon 6. qRT-PCR was
used to measure the mRNA level. Data were normalized to Gapdh (n 5 3; **, p< .01). (E): qRT-PCR was used to determine efficiency
and specificity of isoform-specific knockdown in ESCs. Data were normalized to Gapdh. The expression levels of Tpm1-E5 or Tpm1-E6
were significantly decreased by E5 or E6 siRNA, respectively (n 5 3, **, p< .01; ***, p< .001). (F): The effect of Tpm1 isoform- specific
knockdown in ESCs as determined by alkaline phosphatase staining (up panel) and immunofluorescence staining of Oct4 (lower panel),
observed at day 3 after electroporation of isoform-specific siRNA. Nuclei were stained with Hoechst (blue). Scale bar5 200 lm. Abbrevi-
ations: Dox, doxycycline; hESC, human embryonic stem cell.
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shown in Figure 7F, KD of Tpm1-E5 but not E6 resulted in ESC
morphological change, reduction of alkaline phosphatase and
Oct4 staining, indicating that ESC specific Tpm1-E5 was func-
tional in ESC and might be involved in the maintenance of
pluripotency. These results suggest that Rbm24 reduced ESC
pluripotency by switching splicing of the pluripotency tran-
scripts toward tissue-specific isoforms. Together, these data
indicate that Rbm24 links splicing with the regulatory compo-
nents that maintain pluripotency by regulating splicing of
transcripts encoding pluripotency related factors.
DISCUSSION
Cellular differentiation requires global changes in regulatory
networks at all levels of gene expression. Post-transcriptional
gene regulation offers a mechanism for rapid changes in the
cellular proteome. In particular, AS represents a wide range
acting mode of gene regulation, yet its role in regulating ESC
pluripotency and differentiation remains poorly understood.
The transition of ESC pluripotency to differentiation is accom-
panied by an expansion of mRNA diversity and an increase in
cellular complexity. Cell type-specific splicing which can gener-
ate different transcript variants is a key process underlying
post-transcriptional regulation and contributes to proteomic
diversity.
A large number of AS events, where primary transcripts
are differentially processed to structurally and functionally dis-
tinct mRNA isoforms, were detected between ESC/iPSC
(induced pluripotent stem cells) and non-ESC/tissues, and
were also found to play a role in the transition of ESC fate [5,
6, 9, 10]. These findings highlight the critical role of AS in the
specification of ESCs during differentiation. However, only a
few tissue-specific splicing factors have been found to play a
major role in cell fate determination in ESC [2]. An ESC-
specific splicing switch in Foxp1 transcripts has been reported
to play a role in the maintenance of pluripotency [6]. More
recently, Mbnl proteins were found to inhibit ESC-specific AS
[8]. iPSC factor Lin28 plays important roles in pluripotency
and development as a repressor of microRNA processing and
as a post-transcriptional regulatory factor for a subset of key
mRNAs [35].
In this study, we report that RBP Rbm24, a splicing regula-
tor, plays an essential role in modulating post-transcriptional
networks between ESC maintenance and cell-type specifica-
tion. By using an inducible ESC line overexpressing Rbm24 in
combination with RNA-seq, we identified more than 200 AS
events that were regulated by Rbm24. Our results expand on
recent reports establishing the critical roles of Rbm24 in heart
development [14, 16]. Rbm24 has been reported as a major
regulator of AS in striated muscle [16]. Here, we find that
Rbm24 regulates ESC commitment into cardiac lineage differ-
entiation through direct regulation of gene splicing in broad
categories. The functional classes of genes that are regulated
by Rbm24 splicing comprise both, which are those with wide-
spread homeostatic activities and those with cell-type-specific
functions, including transcription factors, sarcomeric proteins
for cytoskeleton assembly, and ATPase for fast energy supply.
This finding offers a global view about how a RBP such as
Rbm24 influences cell fate by AS regulation.
Interestingly, our analysis of overlap between the tran-
scriptome of differentiated cardiomyocytes and undifferenti-
ated ESC reveals a subset of common genes that are highly
expressed in both distinct cell types, indicating great diversity
in isoforms expression during ESC transition into the differen-
tiated state. This is in line with earlier observation of a
genome-wide comparison of AS in human ESCs with neural
progenitor cells [9]. We observed that Tpm1, a muscle specific
gene encoding a protein in the thin filaments of sarcomere,
possessed ESC-specific isoform that was required for mainte-
nance of ESCs. KD of ESC-specific isoform markedly affected
the maintenance of ESC pluripotency (Fig. 7). Tpm1 transcript
was alternatively spliced into a cardiac-specific isoform by
Rbm24 during ESC differentiation into cardiomyocytes (Fig.
7B, 7C). The isoform switch of Tpm1 may contribute to the
differentiation phenotype induced by Rbm24. Similar observa-
tions were reported for Foxp1 whose DNA-binding preference
is changed by AS regulation of RBP Mbnl [8]. The ESC-specific
isoform of FOXP1 stimulates the expression of transcription
factor genes required for pluripotency, including Oct4, Nanog,
Nr5a2, and Gdf3, while concomitantly repressing expression
of genes required for ESC differentiation [6].
Given that hundreds of ESC-specific AS events are
detected, and many RBPs are differentially expressed between
ESCs and differentiated tissues, it is plausible that tissue-
specific RBPs could function by AS regulation to produce alter-
nate mRNA isoforms with tissue specific functions, as exempli-
fied by Rbm24 gene here. This mutually exclusive expression
of two or more alternative gene products from a single tran-
script modulated by RBPs could allow for ESC efficient and
rapid transition from an undifferentiated to a differentiated
state, and probably represents a broad regulatory mechanism
in stem cell differentiation and developmental biology.
Interestingly, a growing number of studies revealed that
cell adhesion molecules and extracellular matrices could medi-
ate cohesive interaction among stem cells and contribute sig-
nificantly to their self-renewal and differentiation via
cytoskeletal reorganization-signaling [36–39]. We observed
that Rbm24 regulated a cluster of AS events associated with
the cytoskeleton during cardiac differentiation of ESCs, includ-
ing Tpm1, Tpm3, and Capzb. We speculate that Rbm24 could
trigger the reorganization of the cytoskeleton, and the result-
ant mechanical force could further shape the stem cells and
subsequently alter the extracellular signaling, leading to differ-
entiation of ESC.
Thus far, the roles of RBPs in heart development have
been largely constricted to studies during postnatal stage
[40], focusing on AS changes that drive fetal-to-adult transi-
tions [2]. Celf1 and Mbnl1 proteins are reported with deter-
minative roles that drive these developmental transitions [41].
Unfortunately, the early molecular mechanism that is respon-
sible for the specification of cardiovascular cell fate from
undifferentiated ESCs remains largely unknown [42, 43]. In
this study, we show that the process of ESC differentiation
allows for the dissection of the cellular and molecular mecha-
nisms underlying cell fate decision. Using an inducible mouse
ESC differentiation system, we specifically investigated the
earliest molecular events orchestrating the transition of ESCs
to a differentiated state. We have found that Rbm24 is
required in early ESC cardiogenesis and can direct cardiovas-
cular progenitor specification through AS regulation. To our
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knowledge, our study provides the first comprehensive insight
into how a tissue-specific RBP directs ESC commitment to car-
diac lineage specification by regulating AS.
One potential confounding factor in our approach is that
Dox-treatment process itself might somehow alter the gene
expression or splicing in cells. The A2Lox inducible ESC line is
a well-established system and has been widely used to study
the function of targeted genes by Dox induction [19, 44–46],
so far none of these studies suggested that Dox had an effect
on gene expression. To examine the potential possibility of
Dox effect in our study, we analyzed the AS events of Rbm24
target genes by RT-PCR in wild type A2Lox cells, no difference
was observed for AS pattern in Dox-treated versus untreated
cells (data not shown). Furthermore, the Rbm24-regulated AS
events were validated in Rbm24 KD cells using R1 ESCs where
no Dox treatment was involved (Fig. 6E). These results com-
bined with the ESC cardiac differentiation functional data indi-
cate that AS events found in our study are result from Rbm24
regulation, not Dox addition itself.
CONCLUSION
In conclusion, our results identify the regulation of a post-
transcriptional switch by Rbm24 as a novel mechanism which
alters a constitutively present pool of transcripts to express
different isoforms. This leads to the functionalization of cells
in tissues during ESC lineage differentiation, which in our case
is the differentiation of ESCs into cardiomyocytes. These find-
ings would significantly add to the understanding of the
mechanisms in ESC differentiation and heart development,
and uncover potential novel pathways operating to direct dif-
ferentiation of ESCs.
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